Brief: Silo Pharma Announces Positive Results In Alzheimer’S Disease Study
24/01/2024 16:20
Jan 24 (Reuters) - Silo Pharma Inc SILO.O :
* SILO PHARMA ANNOUNCES POSITIVE RESULTS IN ALZHEIMER’S
DISEASE
STUDY
* SILO PHARMA INC - PRECLINICAL STUDY SHOWS SPC-14'S
EFFECTIVENESS
AGAINST LH (LUTEINIZING HORMONE) STRESS, HELPLESSNESS, AND
ANXIETY
* SILO PHARMA INC - ITS ALZHEIMER'S DISEASE THERAPEUTIC
SPC-14
SHOWED POSITIVE EFFICACY IN SMALL ANIMALS
Source text for Eikon: ID:nGNXbdBqkv
Further company coverage: SILO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Silo Pharma
See all newsBrief: Silo Pharma - Enters Asset Purchase Agreement With Larry King On October 13, 2026 - SEC Filing
Brief: Silo Pharma Enters Asset Purchase Agreement With Norsight Consulting On Oct 1 - SEC Filing
Brief: Silo Pharma Enters Asset Purchase Agreement With Parkview Consulting
Brief: Silo Pharma Selling Shareholders Offer On Resale Basis 1.9 Million Shares Of Silo Pharma Common Stock - SEC Filing
Brief: Silo Pharma Regains Compliance With Nasdaq Minimum Bid Price Requirement